Telix Pharmaceuticals | TLX - Ordinary Share Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Telix Pharmaceuticals

Telix Pharmaceuticals Ltd reported AUD370.97M in Ordinary Share Capital for its fiscal semester ending in December of 2022.


Ordinary Share Capital Change
Cochlear COH:AU AUD 1.28B 100K
Integral Diagnostics Ltd IDX:AU AUD 333.08M 10.54M
Mayne Pharma MYX:AU AUD 1.24B 0
Opthea Ltd OPT:AU USD 320.59M 85.31M
Pacific Edge PEB:NZ NZD 294.32M 87K
Paradigm Biopharmaceuticals Ltd PAR:AU AUD 209.55M 62.35M
Polynovo Ltd PNV:AU AUD 188.02M 48.59M
PYC Therapeutics Ltd PYC:AU AUD 125.99M 0
Ramsay Health Care RHC:AU AUD 2.2B 0
ResMed RMD:AU USD 588K 2K
Sonic Healthcare SHL:AU AUD 3.76B 106.79M